home / stock / evfm / evfm quote
Last: | $0.4782 |
---|---|
Change Percent: | -36.49% |
Open: | $0.4401 |
Close: | $0.7529 |
High: | $0.59 |
Low: | $0.43 |
Volume: | 51,997,652 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.4782 | $0.4401 | $0.7529 | $0.59 | $0.43 | 51,997,652 | 08-10-2022 |
$0.624 | $0.75 | $0.7529 | $0.76 | $0.58 | 24,899,588 | 08-09-2022 |
$0.8001 | $0.9214 | $0.7529 | $0.9299 | $0.79 | 18,047,669 | 08-08-2022 |
$0.9434 | $1.05 | $0.7529 | $1.11 | $0.901 | 38,159,235 | 08-05-2022 |
$0.898 | $0.881 | $0.7529 | $0.9299 | $0.82 | 14,854,770 | 08-04-2022 |
$0.87 | $0.7621 | $0.7529 | $0.91 | $0.7621 | 16,399,752 | 08-03-2022 |
$0.7649 | $0.7388 | $0.7529 | $0.8099 | $0.721 | 7,207,306 | 08-02-2022 |
$0.7698 | $0.73 | $0.7529 | $0.795 | $0.7151 | 7,744,730 | 08-01-2022 |
$0.73 | $0.8549 | $0.7529 | $0.87 | $0.723 | 15,051,224 | 07-29-2022 |
$0.74 | $0.7529 | $0.7529 | $0.7691 | $0.69 | 8,881,695 | 07-28-2022 |
$0.821 | $0.8479 | $0.8479 | $0.8534 | $0.8 | 6,332,256 | 07-26-2022 |
$0.8623 | $0.88 | $0.8623 | $0.94 | $0.831 | 14,312,679 | 07-25-2022 |
$0.8075 | $0.8675 | $0.8075 | $0.9199 | $0.801 | 13,983,291 | 07-19-2022 |
$0.8781 | $0.7724 | $0.8781 | $1.04 | $0.75 | 39,707,914 | 07-18-2022 |
$0.878 | $1.04 | $0.878 | $1.0498 | $0.84 | 33,571,101 | 07-15-2022 |
$1.07 | $1.13 | $1.07 | $1.14 | $1.04 | 13,140,500 | 07-14-2022 |
$1.15 | $1.17 | $1.15 | $1.3 | $1.13 | 18,410,344 | 07-13-2022 |
$1.24 | $1.14 | $1.24 | $1.24 | $1.09 | 26,416,595 | 07-12-2022 |
$1.11 | $1.27 | $1.11 | $1.29 | $1.09 | 28,980,886 | 07-11-2022 |
$1.35 | $1.36 | $1.35 | $1.45 | $1.27 | 60,706,371 | 07-08-2022 |
News, Short Squeeze, Breakout and More Instantly...
Evofem Biosciences Inc. Company Name:
EVFM Stock Symbol:
NASDAQ Market:
Evofem Biosciences Inc. Website:
Evofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO PR Newswire -- Application allowed with broad method claims that are Orange Book-listable -- -- Once issued, this will be Evofem's fifth patent covering Hormone-Free "In th...
Aditxt (NASDAQ: ADTX) previously entered into a definitive agreement to acquire Evofem Biosciences Inc. (OTCQB: EVFM) , which is believed to represent a compelling opportunity to accelerate Evofem’s growth trajectory, as a subsidiary of Aditxt, into a multi-product women’s health ...